Ferrieri Giovanni B, Castiglioni Stefano, Carmagnola Daniela, Cargnel Marco, Strohmenger Laura, Abati Silvio
Department of Medicine, Università degli Studi di Milano, Milano, Italy.
J Oral Maxillofac Surg. 2007 Jun;65(6):1149-54. doi: 10.1016/j.joms.2006.11.015.
Conflicting opinions exist in literature concerning the management of oral surgery in patients on oral anticoagulants because no consensus on perioperative protocols is available, including precise guidelines regarding the need for therapy modification or withdrawal. The aim of this study was to evaluate bleeding complications associated with oral surgery performed on patients on oral anticoagulants without therapy modification or withdrawal but following a standardized comprehensive perioperative management protocol.
Patients on oral anticoagulant therapy with warfarin and in need of oral surgery underwent a thorough general and oral clinical evaluation to assess thromboembolic and bleeding risk; 255 subjects who, on the morning of surgery, had INR values <or=5.5 were included in the study. An atraumatic surgical technique was carried out and all patients received postoperative careful instructions.
Five cases (1.96%) of bleeding complication were observed in patients with moderate to high thromboembolic and bleeding risk.
The findings from this study suggest that a comprehensive perioperative management protocol for oral surgery in patients on oral anticoagulants including 1) thromboembolic and bleeding risk assessment, 2) an atraumatic surgical technique, and 3) postoperative careful instructions, can lead to safe and successful results with minimal complications.
关于口服抗凝剂患者口腔外科手术的管理,文献中存在相互矛盾的观点,因为对于围手术期方案尚无共识,包括关于治疗调整或停药必要性的精确指南。本研究的目的是评估在未进行治疗调整或停药但遵循标准化综合围手术期管理方案的情况下,口服抗凝剂患者进行口腔外科手术后的出血并发症。
接受华法林口服抗凝治疗且需要进行口腔外科手术的患者接受了全面的全身和口腔临床评估,以评估血栓栓塞和出血风险;255名在手术当天早晨国际标准化比值(INR)≤5.5的受试者被纳入研究。采用了无创手术技术,所有患者术后均接受了仔细的指导。
在血栓栓塞和出血风险为中度至高风险的患者中观察到5例(1.96%)出血并发症。
本研究结果表明,针对口服抗凝剂患者口腔外科手术的综合围手术期管理方案,包括1)血栓栓塞和出血风险评估、2)无创手术技术以及3)术后仔细指导,能够以最少的并发症实现安全且成功的手术效果。